ENGAGE 1-10003-400Recalls & reported problems
Smith & Nephew, Inc. · POROUS COATED FEMORAL COMP SIZE 4-RIGHT MEDIAL · Class 2 · Implant
All models of ENGAGE (80)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00885556872987), received between May 9, 2022 and Jun 4, 2024 — classified as 6 injuries.
The most frequently reported specific device problem is “Failure to Osseointegrate” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
4 other recalls cover devices cleared under the same FDA submission (K190439, K230653); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- May 2, 2023Class IIOpen, Classified
Recent complaint data indicates that the revision rate may be trending higher than corresponding similar devices in global joint replacement registries. The data identifies a potential signal that the performance is an outlier versus the state of the art with respect to the risk for revision.
Z-1670-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Failure to Osseointegrate1
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Pain4
- Arthralgia2
- Abscess1
- Failure of Implant1
- Inadequate Osseointegration1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryJun 4, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, AFTER A TKA SURGERY WAS PERFORMED ON (B)(6) 2022, THE PATIENT EXPERIENCED PAIN. THIS ADVERSE EVENT WAS TREATED BY A REVISION SURGERY ON (B)(6) 2024, IN WHICH A ENGAGE TIBIAL ANCHOR STEM SZ 3-4, ENGAGE POROUS FEMORAL SZ 4-RT MED, ENGAGE POROUS TIBIAL TRAY SZ 3-RT MED AND THE ENGAGE TIBIAL INSERT SZ 3-RT MED 9MM WERE EXCHANGED. PATIENT'S CURRENT HEALTH STATUS IS UNKNOWN.
Patient problems: Pain
MAUDE report 19459857 ↗InjuryAug 17, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, AFTER A TKA SURGERY HAD BEEN PERFORMED ON (B)(6) 2023, A REVISION SURGERY HAD TO BE PERFORMED ON (B)(6) 2023 BECAUSE THE PATIENT HAD PAIN IMMEDIATELY AFTER IMPLANTATION THAT DID NOT SUBSIDE. CURRENT HEALTH STATUS OF PATIENT IS UNKNOWN.
Patient problems: Pain
MAUDE report 17564731 ↗InjuryMay 26, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, AFTER A PARTIAL KNEE REPLACEMENT SURGERY PERFORMED ON (B)(6) 2021, THE PATIENT REPORTED WEIGHT BEARING PAIN AT THE JOINT LINE 6 MONTHS POST-OP. SURGEON RECOMMENDED PATIENT TO WAIT AS PRIOR EXPERIENCE AND LITERATURE SUGGESTS THAT PAIN WOULD RESOLVE AS IMPLANTS SETTLED IN OVER TIME. PATIENT WAS REPORTEDLY NOT WILLING TO WAIT AND OPTED FOR A REVISION TO A TKA. SURGEON NOTED THAT HER LONG LIMB ALIGNMENT POST-SURGERY WAS ¿NOT THAT GREAT¿. PATIENT WAS SUCCESSFULLY CONVERTED TO A CEMENTED PRIMARY TKA ON (B)(6) 2021 WITH NO AUGMENTS AND MINIMAL BONE LOSS DUE TO THE REVISION PROCEDURE. ALSO, SURGEON NOTED THAT PATIENT MAY NOT HAVE BEEN A GOOD CANDIDATE FOR CEMENTLESS UKA AS SHE HAD A TIBIA VARA DEFORMITY IN HER LEFT TIBIA THEY MAY HAVE CONTRIBUTED TO HER PAIN.
Patient problems: Pain
MAUDE report 17011275 ↗InjuryApr 13, 2023Failure to Osseointegrate; Failure to Osseointegrate
IT WAS REPORTED THAT AFTER AN UKR SURGERY WAS PERFORMED IN JUNE OF 2022 USING AN ENGAGE SYSTEM, THE PATIENT HAD PERSISTENT PAIN. A REVISION SURGERY WAS PERFORMED ON (B)(6) 2023, ON WHICH THE ENGAGE POROUS FEMORAL SZ 4-RT MED DEVICE WAS FOUND TO BE RELATIVELY LOOSE WITH JUST FIBROUS ON-GROWTH. CURRENT HEALTH STATUS OF PATIENT IS UNKNOWN.
Patient problems: Arthralgia; Inadequate Osseointegration
MAUDE report 16735882 ↗InjuryJan 18, 2023Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
IT WAS REPORTED THAT, AFTER A PKA SURGERY, THE PATIENT EXPERIENCED A LOOSENING OF THE ENGAGE CEMENTLESS PARTIAL KNEE ST. THIS ADVERSE EVENT WAS SOLVED BY REVISION SURGERY ON (B)(6) 2022. CURRENT HEALTH STATUS OF PATIENT IN UNKNOWN.
Patient problems: Failure of Implant
MAUDE report 16199481 ↗InjuryMay 9, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, AFTER AN UNICOMPARTMENTAL KNEE ARTHROPLASTY HAD BEEN PERFORMED ON (B)(6) 2021, THE PATIENT EXPERIENCED PAIN AND DEVELOPED A SUTURE ABSCESS 6-7 WEEKS POSTOPERATIVELY. A REVISION SURGERY WITH AN IRRIGATION AND DEBRIDEMENT (I&D) WAS PERFORMED ON (B)(6) 2021 TO TREAT THIS ADVERSE EVENT. AS PART OF THE INTERVENTION PERFORMED, THE FEMORAL COMPONENT AND THE TIBIAL INSERT WERE REMOVED WITH STANDARD INSTRUMENTATION AND REPLACED WITH NEW CEMENTED IMPLANTS. THE PATIENT'S OUTCOME IS UNKNOWN.
Patient problems: Abscess; Arthralgia; Pain
MAUDE report 14335942 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K190439, K230653. One submission often covers many models, so check the product and lot details in each record.
- Z-2621-2023 · Aug 31, 2023 · Open, Classifiedsmith&nephew LEGION OXINUM POSTERIOR STABILIZED NONPOROUS FERMOAL COMPONENT, SIZE 5N, LEFT, NARROW, REF 71421265; knee joint
- Z-1672-2023 · May 2, 2023 · Open, ClassifiedSmith&Nephew ENGAGE Cementless Partial Knee System, Coated Tibial Tray, Part Numbers: a) REF 1-10012-100, SIZE 1-LEFT MEDIAL; b) REF 1-10012-150, SIZE 1-RIGHT MEDIAL; c) REF 1-1
- Z-1673-2023 · May 2, 2023 · Open, ClassifiedSmith&Nephew ENGAGE Cementless Partial Knee System, Coated Tibial Insert, Part Numbers: a) REF 1-10013-109, SIZE 1-LEFT MED, 9MM; b) REF 1-10013-110, SIZE 1-LEFT MED, 10MM; c)
- Z-1671-2023 · May 2, 2023 · Open, ClassifiedSmith&Nephew ENGAGE Cementless Partial Knee System, Tibial Anchor Stem, Part Numbers: a) REF 1-10011-100 (SIZE 1-2), b) REF 1-10011-200 (SIZE 3-4), c) REF 1-10011-300 (SIZE 5-6
Other PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- LinkSymphoKnee 880-307/21WALDEMAR LINK GmbH & Co. KG · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls2 reports
- Scorpio 73-3710Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls1 report
- Scorpio 73-3110Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls0 reports
- Arthrex® AR-503-TTTEArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall14 reports
- Arthrex® AR-503-TTTJArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall9 reports
- ENGAGE 1-10011-300Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- Arthrex® AR-503-TTTGArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- ENGAGE 1-10012-550Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page